Skip to content
lifestyle.luxedb.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Ambrosia Biosciences
Ambrosia Biosciences Announces the Nonclinical Data Profiles of Two Oral Small Molecule Programs: A GLP-1 Receptor Agonist Intended for Once-Weekly Dosing and a GIP Receptor Antagonist
November 15, 2026
Ambrosia Biosciences Announces Late-Breaking Poster Presentations at ObesityWeek® 2026
November 10, 2026
Ambrosia Biosciences to Participate in Upcoming Investor Conferences
September 16, 2026